{
  "pmid": "28325636",
  "uid": "28325636",
  "title": "Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis.",
  "abstract": "BACKGROUND: The prognosis of patients with locally advanced penile squamous-cell carcinoma is primarily related to the extent of lymph node metastases. Surgery alone yields suboptimal results, and there is a paucity of data on these patients' outcomes. PATIENTS AND METHODS: This retrospective study evaluated patients who received neoadjuvant or adjuvant chemotherapy from 1990 onward at 12 centers. Cox models were used to investigate prognostic factors for relapse-free survival and overall survival (OS). RESULTS: Among the 201 included patients, 39 (19.4%) had disease of T3-4 and N0 clinical stage; the remaining patients had clinical lymph node involvement (cN+). Ninety-four patients received neoadjuvant chemotherapy (group 1), 78 received adjuvant chemotherapy (group 2), and 21 received both (group 3). Eight patients for whom the timing of perioperative chemotherapy administration was unavailable were included in the Cox analyses. Forty-three patients (21.4%) received chemoradiation. Multivariate analysis for OS (n = 172) revealed bilateral disease (P = .035) as a negative prognostic factor, while pelvic cN+ tended to be nonsignificantly associated with decreased OS (P = .076). One-year relapse-free survival was 35.6%, 60.6%, and 45.1% in the 3 groups, respectively. One-year OS was 61.3%, 82.2%, and 75%, respectively. No significant differences were seen on univariable analyses for OS between the groups (P = .45). Platinum type of chemotherapy and chemoradiation were not significantly associated with any outcome analyzed. CONCLUSION: Benchmark survival estimates for patients receiving perioperative chemotherapy for locally advanced penile squamous-cell carcinoma have been provided, with no substantial differences observed between neoadjuvant and adjuvant administration. This analysis may result in improved patient information, although prospective studies are warranted.",
  "authors": [
    {
      "last_name": "Necchi",
      "fore_name": "Andrea",
      "initials": "A",
      "name": "Andrea Necchi",
      "affiliations": [
        "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: andrea.necchi@istitutotumori.mi.it."
      ]
    },
    {
      "last_name": "Pond",
      "fore_name": "Gregory R",
      "initials": "GR",
      "name": "Gregory R Pond",
      "affiliations": [
        "McMaster University, Hamilton, Ontario, Canada."
      ]
    },
    {
      "last_name": "Raggi",
      "fore_name": "Daniele",
      "initials": "D",
      "name": "Daniele Raggi",
      "affiliations": [
        "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy."
      ]
    },
    {
      "last_name": "Ottenhof",
      "fore_name": "Sarah R",
      "initials": "SR",
      "name": "Sarah R Ottenhof",
      "affiliations": [
        "The Netherlands Cancer Institute, Amsterdam, The Netherlands."
      ]
    },
    {
      "last_name": "Djajadiningrat",
      "fore_name": "Rosa S",
      "initials": "RS",
      "name": "Rosa S Djajadiningrat",
      "affiliations": [
        "The Netherlands Cancer Institute, Amsterdam, The Netherlands."
      ]
    },
    {
      "last_name": "Horenblas",
      "fore_name": "Simon",
      "initials": "S",
      "name": "Simon Horenblas",
      "affiliations": [
        "The Netherlands Cancer Institute, Amsterdam, The Netherlands."
      ]
    },
    {
      "last_name": "Khoo",
      "fore_name": "Vincent",
      "initials": "V",
      "name": "Vincent Khoo",
      "affiliations": [
        "The Royal Marsden Hospital, London, United Kingdom."
      ]
    },
    {
      "last_name": "Hakenberg",
      "fore_name": "Oliver W",
      "initials": "OW",
      "name": "Oliver W Hakenberg",
      "affiliations": [
        "University Hospital Rostock, Rostock, Germany."
      ]
    },
    {
      "last_name": "Draeger",
      "fore_name": "Desiree",
      "initials": "D",
      "name": "Desiree Draeger",
      "affiliations": [
        "University Hospital Rostock, Rostock, Germany."
      ]
    },
    {
      "last_name": "Protzel",
      "fore_name": "Chris",
      "initials": "C",
      "name": "Chris Protzel",
      "affiliations": [
        "University Hospital Rostock, Rostock, Germany."
      ]
    },
    {
      "last_name": "Heidenreich",
      "fore_name": "Axel",
      "initials": "A",
      "name": "Axel Heidenreich",
      "affiliations": [
        "Universitätsklinikum Köln, Köln, Germany."
      ]
    },
    {
      "last_name": "Haidl",
      "fore_name": "Friederike",
      "initials": "F",
      "name": "Friederike Haidl",
      "affiliations": [
        "Universitätsklinikum Köln, Köln, Germany."
      ]
    },
    {
      "last_name": "Eigl",
      "fore_name": "Bernie J",
      "initials": "BJ",
      "name": "Bernie J Eigl",
      "affiliations": [
        "British Columbia Cancer Agency, Vancouver, BC, Canada."
      ]
    },
    {
      "last_name": "Nappi",
      "fore_name": "Lucia",
      "initials": "L",
      "name": "Lucia Nappi",
      "affiliations": [
        "British Columbia Cancer Agency, Vancouver, BC, Canada."
      ]
    },
    {
      "last_name": "Matsumoto",
      "fore_name": "Kazumasa",
      "initials": "K",
      "name": "Kazumasa Matsumoto",
      "affiliations": [
        "Kitasato University School of Medicine, Sagamihara, Japan."
      ]
    },
    {
      "last_name": "Vaishampayan",
      "fore_name": "Ulka",
      "initials": "U",
      "name": "Ulka Vaishampayan",
      "affiliations": [
        "Karmanos Cancer Institute, Detroit, MI."
      ]
    },
    {
      "last_name": "Woods",
      "fore_name": "Michael E",
      "initials": "ME",
      "name": "Michael E Woods",
      "affiliations": [
        "University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC."
      ]
    },
    {
      "last_name": "Salvioni",
      "fore_name": "Roberto",
      "initials": "R",
      "name": "Roberto Salvioni",
      "affiliations": [
        "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy."
      ]
    },
    {
      "last_name": "Nicolai",
      "fore_name": "Nicola",
      "initials": "N",
      "name": "Nicola Nicolai",
      "affiliations": [
        "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy."
      ]
    },
    {
      "last_name": "Catanzaro",
      "fore_name": "Mario",
      "initials": "M",
      "name": "Mario Catanzaro",
      "affiliations": [
        "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy."
      ]
    },
    {
      "last_name": "Giannatempo",
      "fore_name": "Patrizia",
      "initials": "P",
      "name": "Patrizia Giannatempo",
      "affiliations": [
        "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy."
      ]
    },
    {
      "last_name": "Geynisman",
      "fore_name": "Daniel M",
      "initials": "DM",
      "name": "Daniel M Geynisman",
      "affiliations": [
        "Fox Chase Cancer Center Temple Health, Philadelphia, PA."
      ]
    },
    {
      "last_name": "Preto",
      "fore_name": "Mirko",
      "initials": "M",
      "name": "Mirko Preto",
      "affiliations": [
        "Università degli Studi di Torino, Ospedale Molinette, Torino, Italy."
      ]
    },
    {
      "last_name": "Xylinas",
      "fore_name": "Evanguelos",
      "initials": "E",
      "name": "Evanguelos Xylinas",
      "affiliations": [
        "Cochin Hospital, APHP, Paris Descartes University, Paris, France."
      ]
    },
    {
      "last_name": "Milowsky",
      "fore_name": "Matthew I",
      "initials": "MI",
      "name": "Matthew I Milowsky",
      "affiliations": [
        "University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC."
      ]
    },
    {
      "last_name": "De Placido",
      "fore_name": "Sabino",
      "initials": "S",
      "name": "Sabino De Placido",
      "affiliations": [
        "Università Federico II, Napoli, Italy."
      ]
    },
    {
      "last_name": "Di Lorenzo",
      "fore_name": "Giuseppe",
      "initials": "G",
      "name": "Giuseppe Di Lorenzo",
      "affiliations": [
        "Università Federico II, Napoli, Italy."
      ]
    },
    {
      "last_name": "Sonpavde",
      "fore_name": "Guru",
      "initials": "G",
      "name": "Guru Sonpavde",
      "affiliations": [
        "UAB Comprehensive Cancer Center, Birmingham, AL."
      ]
    }
  ],
  "journal": {
    "title": "Clinical genitourinary cancer",
    "iso_abbreviation": "Clin Genitourin Cancer",
    "issn": "1938-0682",
    "issn_type": "Electronic",
    "volume": "15",
    "issue": "5",
    "pub_year": "2017",
    "pub_month": "Oct"
  },
  "start_page": "548",
  "end_page": "555.e3",
  "pages": "548-555.e3",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Multicenter Study"
  ],
  "keywords": [
    "Adult",
    "Aged",
    "Aged, 80 and over",
    "Carcinoma, Squamous Cell",
    "Chemoradiotherapy",
    "Chemotherapy, Adjuvant",
    "Humans",
    "Male",
    "Middle Aged",
    "Neoadjuvant Therapy",
    "Penile Neoplasms",
    "Perioperative Period",
    "Prognosis",
    "Prospective Studies",
    "Survival Analysis",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "28325636",
    "mid": "NIHMS1058545",
    "pmc": "PMC6854657",
    "doi": "10.1016/j.clgc.2017.02.002",
    "pii": "S1558-7673(17)30045-9"
  },
  "doi": "10.1016/j.clgc.2017.02.002",
  "pmc_id": "PMC6854657",
  "dates": {
    "completed": "2018-05-21",
    "revised": "2019-11-15"
  },
  "chemicals": [],
  "grants": [
    {
      "grant_id": "P30 CA022453",
      "agency": "NCI NIH HHS",
      "country": "United States"
    }
  ],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:52:52.191095",
    "pmid": "28325636"
  }
}